Active ingredientDiacereinCat. No. P-D084-001CAS 13739-02-1Family · Pharmaceutical analytical standards
Diacerein
A slow-acting anti-osteoarthritis drug of the anthraquinone family, synthesised in the 1980s: it curbs interleukin-1 beta, a key molecule in joint inflammation, and is used for osteoarthritis of the hip and knee. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.
Did you know?In the liver it turns into rhein, an orange anthraquinone found in rhubarb: as the body eliminates its derivatives, urine can turn yellow or pink, with no clinical consequence.
Go to the active ingredient →Active ingredientDiacereinCat. No. P-D084-001CAS 13739-02-1
Pharmacopoeial impurityDiacerein EP Impurity BCat. No. P-D084-002CAS 481-72-1
Pharmacopoeial impurityDiacerein EP Impurity FCat. No. P-D084-003CAS 13928-72-8
ImpurityAloinCat. No. P-D084-004CAS 1415-73-2
Pharmacopoeial impurityDiacerein EP Impurity HCat. No. P-D084-005CAS 25395-11-3
Pharmacopoeial impurityDiacerein EP Impurity DCat. No. P-D084-006CAS 875535-35-6
Pharmacopoeial impurityDiacerein EP Impurity ECat. No. P-D084-007CAS 875535-36-7
Pharmacopoeial impurityDiacerein EP Impurity GCat. No. P-D084-008CAS 64951-96-8
Isotopically labelledDiacerein-d6Cat. No. P-D084-009CAS 1325559-27-0No product matches your search.
EDQM standards 3
The official European Pharmacopoeia standards for this family.
Reference substanceDiacerein CRSEDQM code Y0001595Family DiacereinImpurityDiacerein impurity B CRSEDQM code Y0001596Family DiacereinImpurityDiacerein impurity mixture CRSEDQM code Y0001597Family DiacereinNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.